Newfeed

Orally available RGT-61159 demonstrates potent inhibition of MYB synthesis and significant anti-tumor activity in a range of xenograft models of adenoid cystic carcinoma (ACC) Data support planned first-in-human Phase 1 clinical trial of RGT-61159 in both ACC and colorectal cancer (CRC) CAMBRIDGE, M

NEW YORK, May 31, 2024 /PRNewswire/ — The global crowdfunding market size is estimated to grow by USD 310.07 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of 14.94% during the forecast period. For more insights on the forecast market size and histor

Magazine made for you.

Featured:

No posts were found for provided query parameters.

Elsewhere: